Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more

Market Watch

FINANCE

SHARES in Wolseley slipped last week as the City digested yet another round of acquisitions from the FTSE 100 products titan.

Wolseley has made 42 ac-quisitions since last August, but this largesse did not entirely impress investors.

Despite broker Numis reiterating an 'add' rating on Wolseley with a target price of £15.50, the stock was marked down 8p to £13.62.

Numis is hosting a building conference next week to drum up interest in Galliford Try, Morgan Sindall, Rok and Anglo-Irish house builder and contractor McInerney.

With Rok posting a positive trading statement last week, Numis re-iterated an 'add' rating on the shares with a target price of 650p, helping the stock up 17p to 590p. Rival brokerage Teather & Greenwood is less convinced and suggests a less bullish target price of 578p and a 'hold' rating.

T&G analyst David Taylor said: 'Rok had Q1 turnover ahead by 36 per cent on a likefor-like basis and is beginning to reap the benefit of past investments. This is the division Rok has to get right to secure the re-rating it craves.'

Elsewhere among the contractors, Carillion firmed 3.75p to 331.75p on comple - tion of the sale of a small part of Mowlem, the contracting rival acquired earlier this year.

With this deal done, broker Bridgewell reiterated a 'buy' rating on Carillion.

Bridgewell is also positive on Balfour Beatty - ahead 8p at 367p - but neutral on contracting and housing outfit Taylor Woodrow.

Shares in Taywood, which does its best to pretend in the City not to have a contracting arm, firmed 9.75p to 392 .75p, with Numis reiterating an 'add' rating up to a 418p target price.